...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Phase 3 BETonMACE Trial is Now Completed. Cognition and CKD Sub-Study Results to be Announced Soon.

Free
Message: Buy-Out

Thanks jonzobot. We will definitely need to get clarification on the sale of the company and how that will effect the shareholders IF we come into a sale situation.

I'm a Zenith shareholder as well so either way is good in my situation but it may have a negative effect for others.

Just so others have an understanding of what we are talking about, if the sale of the IP attracted this royalty scheme and the purchase price was $4 billion, Zenith may be entitled to about $450 million or about $3 per fully diluted share.

 

tada

Share
New Message
Please login to post a reply